Pinnacle Financial Partners Inc Novartis Ag Transaction History

Pinnacle Financial Partners Inc

$4.92 Billion
Q3 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Novartis Ag stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 4,625 shares of NVS stock, worth $458,337. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,625

Previous 4,579 1.0%

Holding current value

$458,337

Previous $487,000 9.03%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$106.13 - $120.89 $4,881 - $5,560	46 Added 1.0%	4,625 $531,000
Q2 2024 Aug 06, 2024	SELL	$92.57 - $107.37 $48,784 - $56,583	-527 Reduced 10.32%	4,579 $487,000
Q1 2024 Apr 30, 2024	SELL	$95.27 - $108.47 $14,957 - $17,029	-157 Reduced 2.98%	5,106 $493,000
Q4 2023 Jan 22, 2024	BUY	$92.27 - $101.54 $62,374 - $68,641	676 Added 14.74%	5,263 $531,000
Q3 2023 Nov 03, 2023	SELL	$94.73 - $105.13 $16,577 - $18,397	-175 Reduced 3.67%	4,587 $467,000
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $10,824 - $12,274	117 Added 2.52%	4,762 $480,000
Q1 2023 Apr 26, 2023	BUY	$80.03 - $92.81 $91,474 - $106,081	1,143 Added 32.64%	4,645 $427,000
Q4 2022 Feb 03, 2023	SELL	$75.55 - $92.52 $20,549 - $25,165	-272 Reduced 7.21%	3,502 $317,000
Q3 2022 Oct 31, 2022	BUY	$74.61 - $87.26 $281,578 - $329,319	3,774 New	3,774 $286,000
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $327,169 - $370,092	-4,084 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$79.7 - $88.13 $111,500 - $123,293	1,399 Added 52.1%	4,084 $357,000
Q3 2021 Oct 26, 2021	BUY	$81.78 - $95.14 $219,579 - $255,450	2,685 New	2,685 $220,000
Q1 2021 Apr 19, 2021	SELL	$83.5 - $98.47 $229,959 - $271,186	-2,754 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$78.07 - $94.43 $16,628 - $20,113	213 Added 8.38%	2,754 $260,000
Q3 2020 Oct 27, 2020	SELL	$82.14 - $91.0 $34,005 - $37,674	-414 Reduced 14.01%	2,541 $221,000
Q2 2020 Jul 28, 2020	BUY	$80.93 - $91.1 $2,104 - $2,368	26 Added 0.89%	2,955 $258,000
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $1,272 - $1,782	-18 Reduced 0.61%	2,929 $242,000
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $14,086 - $15,926	-167 Reduced 5.36%	2,947 $279,000
Q3 2019 Oct 25, 2019	BUY	$85.54 - $94.26 $10,521 - $11,593	123 Added 4.11%	3,114 $270,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $14,853 - $18,281	197 Added 7.05%	2,991 $273,000
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $23,123 - $26,448	-307 Reduced 9.9%	2,794 $268,000
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $25,854 - $28,789	351 Added 12.76%	3,101 $266,000
Q3 2018 Oct 31, 2018	BUY	$66.94 - $77.43 $184,085 - $212,932	2,750 New	2,750 $237,000
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $164,481 - $185,894	-2,534 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$70.39 - $84.15 $80,596 - $96,351	-1,145 Reduced 31.12%	2,534 $205,000
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $42,023 - $45,108	-581 Reduced 13.64%	3,679 $309,000
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $315,836 - $329,170	4,260	4,260 $366,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Account

Pinnacle Financial Partners Inc Novartis Ag Transaction History